Clair Blacketer

Risk of Thyroid Tumors With GLP-1 Receptor Agonists: A Retrospective Cohort Study

Advancing Real-World Evidence Through a Federated Health Data Network (EHDEN): Descriptive Study

Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes

Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab

Abstract 4118762: Large-scale multinational trends in the use of cardioprotective antihyperglycemic agents as first-line therapy in patients with type 2 diabetes and cardiovascular disease: a LEGEND-T2DM study

European Health Data & Evidence Network—learnings from building out a standardized international health data network

Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM

Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study

Representing and utilizing clinical textual data for real world studies: An OHDSI approach

Characteristics and outcomes of COVID-19 patients with COPD from the United States, South Korea, and Europe

Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDIS

COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries

A standardized analytics pipeline for reliable and rapid development and validation of prediction models using observational health data

Thirty-Day Outcomes of Children and Adolescents With COVID-19: An International Experience

Characteristics and outcomes of patients with COVID-19 with and without prevalent hypertension: a multinational cohort study

The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment